The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
Clinical trial NCT05051436 · RECRUITING
Trial details
- NCT number
- NCT05051436
- Sponsor
- Philip Kern
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2026-08-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.